Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small‐molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids
Ezgi Öner, Mustafa Kotmakçı, Anne‐Marie Baird, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Small interfering RNA: Discovery, pharmacology and clinical development—An introductory review
Priyanga Ranasinghe, Melisande Addison, James W. Dear, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 21, pp. 2697-2720
Open Access | Times Cited: 75
Nanotechnological Approaches in Prostate Cancer Therapy: Integration of engineering and biology
Milad Ashrafizadeh, Shahin Aghamiri, Shing Cheng Tan, et al.
Nano Today (2022) Vol. 45, pp. 101532-101532
Open Access | Times Cited: 60
Nano-formulated siRNA-based therapeutic approaches for cancer therapy
Dolly Jain, Shiv Kumar Prajapati, Ankit Jain, et al.
Nano Trends (2023) Vol. 1, pp. 100006-100006
Open Access | Times Cited: 24
Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies
Pu-Sheng Wei, Nagasri Thota, Gresham John, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 366-388
Open Access | Times Cited: 14
Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics
Mina Zare, Rakesh Pemmada, Maya Madhavan, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1620-1620
Open Access | Times Cited: 36
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells
Arianna Rinaldi, Florence Dumas, Jason Thomas Duskey, et al.
International Journal of Pharmaceutics (2024) Vol. 654, pp. 123994-123994
Closed Access | Times Cited: 6
Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract
Yuan Zhang, Juhura G. Almazi, Hui Xin Ong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2408-2408
Open Access | Times Cited: 24
Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy
Dokkari Nagalaxmi Yadav, Mohammad Sadik Ali, Ajinkya Madhukar Thanekar, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 12, pp. 4506-4526
Closed Access | Times Cited: 24
Breast cancer suppression by curcumin-naringenin-magnetic-nano-particles: In vitro and in vivo studies
Mostafa A. Askar, Omama E. El Shawi, omayma Abo zaid, et al.
Tumor Biology (2021) Vol. 43, Iss. 1, pp. 225-247
Open Access | Times Cited: 31
Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems
Hongyan Liu, Xialin Zhu, Yuyan Wei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114065-114065
Open Access | Times Cited: 21
Quality by Design Based Formulation of Xanthohumol Loaded Solid Lipid Nanoparticles with Improved Bioavailability and Anticancer Effect against PC-3 Cells
Vancha Harish, Devesh Tewari, Sharfuddin Mohd, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2403-2403
Open Access | Times Cited: 19
A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applications
Ahmed Abosalha, Waqar Ahmad, Jacqueline L. Boyajian, et al.
Expert Opinion on Drug Discovery (2022) Vol. 18, Iss. 2, pp. 149-161
Closed Access | Times Cited: 19
Combating chemoresistance: Current approaches & nanocarrier mediated targeted delivery
Siuli Shaw, Subrata K. Pore, D.-M. Liu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189261-189261
Closed Access
Advancements in gene therapies targeting mutant KRAS in cancers
Yuhang Wang, Thuỳ Anh Bùi, Xinpu Yang, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Small interfering RNA: From designing to therapeutic in cancer
Jyoti Singh, Abdulaziz S. Saeedan, Gaurav Kaithwas, et al.
Journal of Genetic Engineering and Biotechnology (2025) Vol. 23, Iss. 2, pp. 100484-100484
Closed Access
Delivery of Itgb1-siRNA by triptolide-modified and anti-Flt1 peptide-guided ionizable cationic LNPs for targeted therapy of corneal neovascularization
Yuwen Song, Tingting Xu, Hao Li, et al.
Journal of Controlled Release (2025), pp. 113811-113811
Closed Access
Nanomedicine-RNAi interface: Architypes in prostate cancer therapeutics
Saurabh Shah, Paras Famta, Dadi A. Srinivasarao, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105349-105349
Closed Access | Times Cited: 3
Cationic solid lipid nanoparticles (SLN) complexed with plasmid DNA enhance prostate cancer cells (PC-3) migration
Fernanda Garcia-Fóssa, Marcelo Bispo de Jesus
Nanotoxicology (2024) Vol. 18, Iss. 1, pp. 36-54
Open Access | Times Cited: 3
Co-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy
Behiye Şenel, Ebru Başaran, Evrim Akyıl, et al.
ACS Omega (2024) Vol. 9, Iss. 10, pp. 11671-11685
Open Access | Times Cited: 3
MCT4 Knockdown by Tumor Microenvironment-Responsive Nanoparticles Remodels the Cytokine Profile and Eradicates Aggressive Breast Cancer Cells
Ahmed A. H. Abdellatif, Abdellatif Bouazzaoui, Hesham M. Tawfeek, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 238, pp. 113930-113930
Closed Access | Times Cited: 3
Targeting the epigenome with advanced delivery strategies for epigenetic modulators
Sonia Guha, Yogeswaran Jagadeesan, Murali Monohar Pandey, et al.
Bioengineering & Translational Medicine (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
ANTICANCER LIPID-BASED DRUG DELIVERY SYSTEMS: BASIC KNOWLEDGE AND RECENT APPLICATIONS
Mohamed M. Shehata
Nano TransMed (2024), pp. 100054-100054
Open Access | Times Cited: 3
Clinical pharmacology of siRNA therapeutics: current status and future prospects
Ahmed Abosalha, Jacqueline L. Boyajian, Waqar Ahmad, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 11, pp. 1327-1341
Closed Access | Times Cited: 16
Emerging frontiers in nanomedicine targeted therapy for prostate cancer
Tayo Alex Adekiya, Oluwanifemi Owoseni
Cancer Treatment and Research Communications (2023) Vol. 37, pp. 100778-100778
Open Access | Times Cited: 9
Three-Dimensional Culture Models: Emerging Platforms for Screening The Antitumoral Efficacy of Nanomedicines
Larissa Mayumi Bueno, Marcela Tavares Luiz, Jessyca Aparecida Paes Dutra, et al.
Nanomedicine (2023) Vol. 18, Iss. 7, pp. 633-647
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top